Transbiomed's Merger

Transbiomed raised a round of funding on February 10, 2013. Investors include Amadix.

Transbiomed is a Spanish biotech company aimed at developing new in vitro molecular diagnostics based on genomic and proteomic technologies to target large markets with significant unmet medical needs…

Articles about Transbiomed's Merger: